Kristina Torfgård, Ph.D.

Vice President, Global Project Head

Kristina Torfgård has more than 25 years of experience in drug development covering the full product lifecycle and spanning multiple therapeutic and disease areas, including gastrointestinal, neuroscience, cardiovascular and metabolic disease/diabetes. Prior to joining Albireo, Dr. Torfgård was with AstraZeneca, where she worked for several years in various senior and global leadership roles, including project leadership and different roles in the clinical organization. In particular, at different times she was responsible for the gastrointestinal portfolio through Phase 2, responsible for the Established Cardiovascular Brands portfolio and led in-licensing projects and scientific collaborations. Dr. Torfgård holds a M.Sc. in Pharmacy and a Ph.D. in Clinical Pharmacology.

Team members

Ron Cooper

President and Chief Executive Officer

Martha (Muffy) Carter

Chief Regulatory Officer

Jason Duncan

General Counsel

Per-Göran Gillberg, Ph.D., Prof.

Vice President, Development and Co-Founder

Jan Mattsson, Ph.D.

Chief Operating Officer and Co-Founder

Tom Shea

Chief Financial Officer

Patrick Horn, M.D., Ph.D.

Chief Medical Officer

Kristina Torfgård, Ph.D.

Vice President, Global Project Head